Smoking, coffee intake, and Parkinson's disease: Potential protective mechanisms and components

被引:0
作者
Hong, Sa Weon [1 ]
Page, Rachel [1 ]
Truman, Penelope [1 ]
机构
[1] Massey Univ, Sch Hlth Sci, Wellington 6021, New Zealand
关键词
Parkinson's disease; Smoking; Coffee drinking; Phenolic compounds; Monoamine oxidase B; Catechol O -methyltransferase; CATECHOL-O-METHYLTRANSFERASE; MONOAMINE-OXIDASE-B; 6-HYDROXYDOPAMINE RAT MODEL; NRF2 TRANSCRIPTION FACTOR; NF-KAPPA-B; ALPHA-SYNUCLEIN; CAFFEIC ACID; OXIDATIVE STRESS; FERULIC ACID; MOUSE MODEL;
D O I
10.1016/j.neuro.2024.12.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Parkinson's disease (PD) is a common progressive neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc). Environmental and lifestyle factors, such as smoking and coffee drinking, have been associated with a decreased risk for PD. However, the biological mechanisms underlying protective effects on PD are still not fully understood. It has been suggested that nonnicotine components in cigarette smoke and non-caffeine components in coffee may contribute to this protective effect. The aim of this review was to explore candidate molecules and mechanisms behind the effects of smoking and coffee drinking on PD by integrating findings from previous studies. By cross-referencing an index of tobacco constituents and a list of coffee constituents with existing literature on natural compounds and their structural analogs that show inhibitory activities against monoamine oxidase B, catechol O-methyltransferase, and alpha-synuclein fibrillation, we have identified tobacco and coffee components that inhibit these targets. Furthermore, tobacco and coffee components potentially play roles in suppressing neuroinflammation, activating the Nrf2 pathway as natural activators, and altering the gut microbiome. This review suggests that the phenolic compounds from tobacco and coffee investigated may contribute to the low incidence of PD in smokers and coffee drinkers, showing moderate to strong potential as therapeutic interventions. The current review suggests that multifunctional molecules found in coffee and cigarette smoke may have potential neuroprotective effects, but none of the data indicates that multifunctionality is required for these effects. This review will deepen our understanding of how smoking and coffee drinking are linked to a reduced risk of PD and will also be important in elucidating the mechanisms underlying the protective effects of smoking and coffee drinking on PD.
引用
收藏
页码:48 / 63
页数:16
相关论文
共 50 条
  • [41] Smoking and cognitive function in Parkinson's disease
    Weisskopf, Marc G.
    Grodstein, Francine
    Ascherio, Alberto
    [J]. MOVEMENT DISORDERS, 2007, 22 (05) : 660 - 665
  • [42] Neuroticism, Smoking, and the Risk of Parkinson's Disease
    Sieurin, Johanna
    Zhan, Yiqiang
    Pedersen, Nancy L.
    Wirdefeldt, Karin
    [J]. JOURNAL OF PARKINSONS DISEASE, 2021, 11 (03) : 1325 - 1334
  • [43] Systematic analysis of the molecular mechanisms mediated by coffee in Parkinson's disease based on network pharmacology approach
    Li, Fangjun
    Hatano, Taku
    Hattori, Nobutaka
    [J]. JOURNAL OF FUNCTIONAL FOODS, 2021, 87
  • [44] Stroke in Parkinson's disease: a review of epidemiological studies and potential pathophysiological mechanisms
    Elfil, Mohamed
    Bayoumi, Ahmed
    Sayed, Ahmed
    Aladawi, Mohammad
    Aboutaleb, Pakinam E.
    Grieb, Lauren
    Tolba, Hatem
    Tinaz, Sule
    [J]. ACTA NEUROLOGICA BELGICA, 2023, 123 (03) : 773 - 783
  • [45] Neuroprotective potential of chrysin in Parkinson's disease: Molecular mechanisms and clinical implications
    Angelopoulou, Efthalia
    Pyrgelis, Efstratios-Stylianos
    Piperi, Christina
    [J]. NEUROCHEMISTRY INTERNATIONAL, 2020, 132
  • [46] Advances in the Mechanisms of Parkinson's Disease
    Tolleson, Christopher M.
    Fang, John Y.
    [J]. DISCOVERY MEDICINE, 2013, 15 (80) : 61 - 66
  • [47] Icariin: A Potential Neuroprotective Agent in Alzheimer's Disease and Parkinson's Disease
    Khezri, Mohammad Rafi
    Ghasemnejad-Berenji, Morteza
    [J]. NEUROCHEMICAL RESEARCH, 2022, 47 (10) : 2954 - 2962
  • [48] Genetic insights into immune mechanisms of Alzheimer's and Parkinson's disease
    Nott, Alexi
    Holtman, Inge R.
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [49] Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
    Hong, Dong-Pyo
    Fink, Anthony L.
    Uversky, Vladimir N.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2009, 1794 (02): : 282 - 290
  • [50] Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
    Yan, Run
    Zhang, Jie
    Park, Hye-Jin
    Park, Eun S.
    Oh, Stephanie
    Zheng, Haiyan
    Junn, Eunsung
    Voronkov, Michael
    Stock, Jeffry B.
    Mouradian, M. Maral
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (51) : E12053 - E12062